The Liquid Biopsy Market was valued at USD 13.31 billion in 2025 and is projected to reach USD 36.51 billion by 2034, expanding at a CAGR of 11.9% from 2026 to 2034, according to Polaris Market Research. The 2026 value is USD 14.86 billion. For diagnostics developers, laboratories and investors, the underlying science matters as much as the headline figures. This article reviews the biomarkers,...